Search
Last update: : 07.12.2021
The development of immunotherapies against blood cancer could be more successful if T cells are activated moderately rather than excessively. Scientists from the German Cancer Research Center have…
Press releaseLast update: : 29.11.2021
In multiple myeloma, a cancer of the bone marrow, relapse almost always occurs after treatment. Initially, most patients respond well to therapy. However, as the disease progresses, resistant cancer…
Press releaseLast update: : 23.11.2021
The Accademia Nazionale dei Lincei, Italy's national science academy, has awarded this year's Francesco De Luca Prize to Donato Inverso from the German Cancer Research Center (DKFZ) in recognition of…
Press releaseLast update: : 18.11.2021
Treatment resistance is a central problem in the treatment of cancer. Bone and soft tissue tumors – known as sarcomas – in adolescents and young adults often stop responding to treatment too. This is…
Press releaseLast update: : 18.11.2021
As cancer progresses, the tumor cells continually change, ultimately resulting in a tumor consisting of a large number of different cell clones with different characteristics. This is referred to as…
Press releaseLast update: : 16.11.2021
Scientists of the Translational Lung Research Center Heidelberg (TLRC) and the German Cancer Research Center (DKFZ) have discovered a new link between excessive airway mucus and chronic airway…
Press releaseLast update: : 15.11.2021
Doctors and scientists from the German Cancer Research Center (DKFZ) and from Heidelberg University's Medical Faculty Mannheim have successfully tested a neoantigen-specific transgenic immune cell…
Press releaseLast update: : 08.11.2021
Scientists are obliged to make all the reagents cited in their specialist publications available to their colleagues throughout the world. These include what are known as plasmids – ring-shaped DNA…
Press releaseLast update: : 28.10.2021
The development of therapy resistance often prevents advanced colorectal cancer from being successfully treated in the long term. Scientists from the German Cancer Consortium (DKTK), partner site at…
Press releaseLast update: : 27.10.2021
To translate results from academic research in the Rhine-Main-Neckar life science region, the drug discovery and development company Evotec, in collaboration with Bristol Myers Squibb, recently…
Press release